Concepedia

Alexandre Côté

AC

Statistics

Publications

30

Citations

1.9K

H-Index

24

Active since

2003

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Université de Montréal

WuXi AppTec (China)

Morpho (United States)

Alexandre Côté is an author at Constellation Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2003–2024

30

Publications

30

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials

Brian K. Albrecht, Victor Gehling, Michael C. Hewitt et al. · Journal of Medicinal Chemistry · 2016 · 215 citations · Full text

, , +15

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors

F. Anthony Romero, Alexander M. Taylor, Terry D. Crawford et al. · Journal of Medicinal Chemistry · 2015 · 189 citations · Full text

, , +8

Asymmetric, Catalytic Synthesis of α-Chiral Amines Using a Novel Bis(phosphine) Monoxide Chiral Ligand

Alessandro A. Boezio, Julien Pytkowicz, Alexandre Côté et al. · Journal of the American Chemical Society · 2003 · 158 citations

, , +13

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 118 citations · Full text

, , +12

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)

Alexander M. Taylor, Alexandre Côté, Michael C. Hewitt et al. · ACS Medicinal Chemistry Letters · 2016 · 112 citations · Full text

, , +14

1–5 of 30